AMAG Pharmaceuticals EPS of $4.67 AMAG Pharmaceuticals (NASDAQ:AMAG): Q4 EPS of $4.67 may not be comparable to consensus of $0.30. Revenue of $53.3M (+145.5% Y/Y) beats by $0.61M.